Chiara Maria Soldavini

Dr. Chiara Maria Soldavini

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Lombardy, Italy
+1
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 February 2020 in Nutrients
Verified
Journal Article
Open access
PDF file
GPGabriele Piuri
Gabriele Piuri
KBKatia Basello
Katia Basello
GRGabriele Rossi
Gabriele Rossi
CSChiara Maria Soldavini
Chiara Maria Soldavini
SDSilvia Duiella
Silvia Duiella
FMFerrazzi Enrico Maria
Ferrazzi Enrico Maria
Background: In gestational diabetes mellitus (GDM), pancreatic β-cell breakdown can result from a proinflammatory imbalance created by a sustained level of cytokines. In this study, we investigated the role of specific cytokines, such as B-cell activating factor (BAFF), tumor necrosis factor α (TNF-α), and platelet-activating factor (PAF), together with methylglyoxal (MGO) and glycated albumin (GA) in pregnant women affected by GDM. Methods: We enrolled 30 women whose inflammation and metabolic markers were measured at recruitment and after 12 weeks of strict dietetic therapy. We compared these data to the data obtained from 53 randomly selected healthy nonpregnant subjects without diabetes, hyperglycemia, or any condition that can affect glycemic metabolism. Results: In pregnant women affected by GDM, PAF levels increased from 26.3 (17.4–47.5) ng/mL to 40.1 (30.5–80.5) ng/mL (p < 0.001). Their TNF-α levels increased from 3.0 (2.8–3.5) pg/mL to 3.4 (3.1–5.8) pg/mL (p < 0.001). The levels of methylglyoxal were significantly higher in the women with GDM (p < 0.001), both at diagnosis and after 12 weeks (0.64 (0.46–0.90) μg/mL; 0.71 (0.47–0.93) μg/mL, respectively) compared to general population (0.25 (0.19–0.28) μg/mL). Levels of glycated albumin were significantly higher in women with GDM (p < 0.001) only after 12 weeks from diagnosis (1.51 (0.88–2.03) nmol/mL) compared to general population (0.95 (0.63–1.4) nmol/mL). Conclusion: These findings support the involvement of new inflammatory and metabolic biomarkers in the mechanisms related to GDM complications and prompt deeper exploration into the vicious cycle connecting inflammation, oxidative stress, and metabolic results.

2 January 2020 in Acta Obstetricia et Gynecologica Scandinavica
Verified
Journal Article
Closed access
PDF file
FDFrancesco D'Ambrosi
Francesco D'Ambrosi
GRGabriele Rossi
Gabriele Rossi
CSChiara Maria Soldavini
Chiara Maria Soldavini
MMMatteo Di Maso
Matteo Di Maso
ICIlma F. Carbone
Ilma F. Carbone
FMFerrazzi Enrico Maria
Ferrazzi Enrico Maria

8 December 2021 in Pregnancy Hypertension
Verified
Journal Article
Closed access
CSChiara Maria Soldavini
Chiara Maria Soldavini
DMDaniela Di Martino
Daniela Di Martino
ESElisa Sabattini
Elisa Sabattini
SOSara Ornaghi
Sara Ornaghi
VSVittoria Sterpi
Vittoria Sterpi
FMFerrazzi Enrico Maria
Ferrazzi Enrico Maria

16 June 2022 in Nutrients
Verified
Journal Article
Open access
PDF file
CSChiara Maria Soldavini
Chiara Maria Soldavini
GPGabriele Piuri
Gabriele Piuri
GRGabriele Rossi
Gabriele Rossi
PCPaola Corsetto
Paola Corsetto
LBLinda Benzoni
Linda Benzoni
FMFerrazzi Enrico Maria
Ferrazzi Enrico Maria
Gestational diabetes mellitus (GD) is characterized by glycemic and lipid metabolism alterations in an environment of low-grade inflammation. Our trial aimed to assess the effect of nutraceutical supplements (omega-3 fatty acids, anthocyanins, and alpha-cyclodextrins) in GD patients and evaluate the role of anthropometric, metabolic, and inflammatory parameters as biomarkers to identify subjects who require pharmacological hypoglycemic treatment during gestation. Pregnant women with GD at 24–28 weeks of gestation were enrolled in a double-blind trial and randomized to receive either nutraceutical supplements or a placebo for 12 weeks. No statistically significant differences were observed between the two groups in blood and urine measurements of metabolic, inflammatory, and antioxidant parameters. In the whole cohort, pre-pregnancy BMI and anthropometric measurements were significantly different in patients who required pharmacological intervention. These patients showed higher triglycerides, CRP, and insulin levels and gave birth to newborns with significantly higher weights. Subjects with a greater AA/EPA ratio had higher PAF levels and gave birth four days earlier. In conclusion, one-to-one nutritional coaching and poor compliance with nutraceutical supplementation might have outweighed the impact of this intervention. However, triglyceride concentration and the AA/EPA ratio seems to be a biomarker for higher inflammatory levels and GD candidates for pharmacological treatment. An adequate assumption of omega-3 in women with GD, either by a controlled diet or by nutraceutical supplementation, reduces the need for pharmacological therapy.

7 January 2021 in Archives of Gynecology and Obstetrics
Verified
Journal Article
Closed access
PDF file
FDF. D’ambrosi
F. D’ambrosi
GRG. Rossi
G. Rossi
CSChiara Maria Soldavini
Chiara Maria Soldavini
ICI. F. Carbone
I. F. Carbone
GCG. E. Cetera
G. E. Cetera
EFE. Ferrazzi
E. Ferrazzi

1 February 2022 in Fetal Diagnosis and Therapy
Verified
Journal Article
Closed access
PDF file
FDFrancesco D’aMbrosi
Francesco D’aMbrosi
GRGabriele Rossi
Gabriele Rossi
MMMatteo Di Maso
Matteo Di Maso
CMCecilia Marino
Cecilia Marino
CSChiara Maria Soldavini
Chiara Maria Soldavini
EFEnrico Ferrazzi
Enrico Ferrazzi
Introduction: The aim of the present study was to evaluate fetal umbilical artery (UA) and middle cerebral artery (MCA) blood flow in patients with gestational diabetes (GD), in order to determine whether minimal anomalies of glucose metabolism may influence fetal placental function. Methods: UA and MCA flows were prospectively measured by transabdominal ultrasound in singleton pregnancies between 34 and 37 weeks of gestation. Results: The study included 35 women with GD and 217 nondiabetic patients. Middle cerebral pulsatility index (PI) was significantly higher in the GD group (mean MCA-PI = 1.82 ± 0.27 vs. 1.71 ± 0.26; p < 0.02). Likewise, MCA peak systolic velocity (MCA-PSV) was higher in the GD group compared to the non-GD group, though the difference was not significant (mean of MCA-PSV = 47.14 ± 8.45 vs. 47.09 ± 11.21; p = 0.98). UA-PI resulted higher in the non-GD group without significant differences (mean of UA-PI = 0.88 ± 0.14 vs. 0.86 ± 0.15; p = 0.32). Conclusions: Our study shows that even in cases of minimal metabolic derangements, GD is characterized by a significant variation in fetal Doppler velocimetry, particularly in the brain.